I'm LongbridgeAI, I can summarize articles.Devyser has launched One Lambda Devyser Chimerism Plus, a next-generation chimerism analysis assay designed for post-allogeneic HSCT monitoring. The new product aims to reduce workflow errors, enhance lab efficiency, and improve ease of use compared to existing assays. This launch expands the collaboration with Thermo Fisher, leveraging their commercial network to broaden distribution and support growth.
- Devyser launched One Lambda Devyser Chimerism Plus, a next-generation chimerism analysis assay for post-allogeneic HSCT monitoring. * Product design targets fewer workflow errors, higher lab efficiency, improved ease of use versus the existing chimerism monitoring assay. * Launch expands the Thermo Fisher collaboration, using Thermo Fisher’s commercial network to broaden distribution and support growth ambitions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Devyser Diagnostics AB published the original content used to generate this news brief on July 16, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here